mutLBSgeneDB |
Gene summary for NKX2-5 |
Gene summary |
Basic gene Info. | Gene symbol | NKX2-5 |
Gene name | NK2 homeobox 5 | |
Synonyms | CHNG5|CSX|CSX1|HLHS2|NKX2.5|NKX2E|NKX4-1|VSD3 | |
Cytomap | UCSC genome browser: 5q34 | |
Type of gene | protein-coding | |
RefGenes | NM_001166175.1, NM_001166176.1,NM_004387.3, | |
Description | NK2 transcription factor related, locus 5cardiac-specific homeobox 1homeobox protein CSXhomeobox protein NK-2 homolog Ehomeobox protein Nkx-2.5tinman paralog | |
Modification date | 20141222 | |
dbXrefs | MIM : 600584 | |
HGNC : HGNC | ||
Ensembl : ENSG00000183072 | ||
HPRD : 02787 | ||
Vega : OTTHUMG00000130522 | ||
Protein | UniProt: P52952 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_NKX2-5 | |
BioGPS: 1482 | ||
Pathway | NCI Pathway Interaction Database: NKX2-5 | |
KEGG: NKX2-5 | ||
REACTOME: NKX2-5 | ||
Pathway Commons: NKX2-5 | ||
Context | iHOP: NKX2-5 | |
ligand binding site mutation search in PubMed: NKX2-5 | ||
UCL Cancer Institute: NKX2-5 | ||
Assigned class in mutLBSgeneDB | B: This gene belongs to targetable_mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0045893 | positive regulation of transcription, DNA-templated | 11431700 | GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 10948187 |
Top |
Ligand binding site mutations for NKX2-5 |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | Y162 | R161W | COAD | 1 | Y162 | Y162C | COAD | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for NKX2-5 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | Y162 | R161W | -0.69506609 | Y162 | Y162C | -0.41079809 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for NKX2-5 from PDB |
Top |
Differential gene expression and gene-gene network for NKX2-5 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for NKX2-5 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0039685 | Tetralogy of Fallot | 13 | Biomarker, GeneticVariation |
umls:C0013069 | Double Outlet Right Ventricle | 2 | Biomarker, GeneticVariation |
umls:C0685889 | Splenic Hypoplasia | 1 | GeneticVariation |
umls:C0004238 | Atrial Fibrillation | 1 | Biomarker |
umls:C0027126 | Myotonic Dystrophy | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for NKX2-5 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of NKX2-5 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | NUC | Nucleic Acids | 3rkq | A | Y162 | NUC | Nucleic Acids | 3rkq | B | Y162 | NUC | Nucleic Acids | 4s0h | B | Y162 |
Top |
Conservation information for LBS of NKX2-5 |
Multiple alignments for P52952 in multiple species |
LBS | AA sequence | # species | Species | F145 | KPRVLFSQAQV | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | I184 | STQVKIWFQNR | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | K15 | TPFSVKDILNL | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | K183 | TSTQVKIWFQN | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | L144 | RKPRVLFSQAQ | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | N188 | KIWFQNRRYKC | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | Q181 | KLTSTQVKIWF | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | Q187 | VKIWFQNRRYK | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | R142 | RRRKPRVLFSQ | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | R142 | KRRKPRVLFSQ | 1 | Gallus gallus | R168 | LSAPERDQLAS | 2 | Homo sapiens, Mus musculus | R168 | LSAPERDHLAN | 1 | Gallus gallus | R168 | LSPAERDQLAS | 1 | Rattus norvegicus | W185 | TQVKIWFQNRR | 4 | Homo sapiens, Gallus gallus, Mus musculus, Rattus norvegicus | Y162 | FKQQRYLSAPE | 2 | Homo sapiens, Mus musculus | Y162 | FKQQKYLSAPE | 1 | Gallus gallus | Y162 | FKQQRYLSPAE | 1 | Rattus norvegicus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |